Safety of percutaneous tunneled hemodialysis catheter procedures in patients receiving concurrent clopidogrel therapy

Journal of Vascular Access

Volumn 15, Issue 1, 2014, Pages 33-37

  Salazar, Gloria Maria Martinez ^a   Tan, Chieh Suai ^a   Spearman, Kenneth ^a   Wicky, Stephen ^a   Wu, Steven ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bleeding complications; Chronic kidney disease; Clopidogrel; Dialysis access

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FRESH FROZEN PLASMA; WARFARIN; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; BLEEDING; CANNULATION; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; END STAGE RENAL DISEASE; FEMALE; GLOMERULONEPHRITIS; HEMODIALYSIS; HUMAN; HUMAN TISSUE; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; MALE; PARTIAL THROMBOPLASTIN TIME; PUNCH BIOPSY; REAL TIME ECHOGRAPHY; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; TUNNELED PLEURAL CATHETER; UREA BLOOD LEVEL; VEIN OCCLUSION; ANALOGS AND DERIVATIVES; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; CHEMICALLY INDUCED; DEVICE REMOVAL; INDWELLING CATHETER; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME; UNITED STATES;

AGED; BOSTON; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CENTRAL VENOUS CATHETERS; DEVICE REMOVAL; FEMALE; HEMORRHAGE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84896809590     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.5301/jva.5000164     Document Type: Article

References (21)

1. Sarnak MJ, Levey AS. Epidemiology of cardiac disease in dialysis patients. Semin Dial. 1999;12(2):69-76.
2. US Renal Data System. USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United Sates: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD, 2012. Cardiovascular Disease. Available at: http://www.usrds.org/2012/pdf/v2_ch4_12. pdf. Accessed January 06, 2013.
3. Levey AS, Beto JA, Coronado BE, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis. 1998;32(5): 853-906.
4. Jardine MJ, Ninomiya T, Perkovic V, et al. Aspirin is beneficial in hypertensive patients with chronic kidney disease: a posthoc subgroup analysis of a randomized controlled trial. J Am Coll Cardiol. 2010;56(12):956-965.
5. Serebruany VL, Malinin AI, Eisert RM, Sane DC. Risk of bleeding complications with antiplatelet agents: metaanalysis of 338,191 patients enrolled in 50 randomized controlled trials. Am J Hematol. 2004;75(1):40-47.
6. Veitch AM, Baglin TP, Gershlick AH, et al. British Cardiovascular Intervention Society. Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures. Gut. 2008;57(9): 1322-1329.
7. Douketis JD, Berger PB, Dunn AS, et al. The perioperative management of antithrombotic therapy: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 2008;133:299S-339S.
8. Vascular Access Work Group. Clinical practice guidelines for vascular access. Am J Kidney Dis. 2006;48(Suppl 1): S248-S273.
9. Sohal AS, Gangji AS, Crowther MA, Treleaven D. Uremic bleeding: pathophysiology and clinical risk factors. Thromb Res. 2006;118(3):417-422.
10. Patel IJ, Davidson JC, Nikolic B, et al; Standards of Practice Committee, with Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Endorsement. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol. 2012;23(6):727-736.
11. Chassot PG, Delabays A, Spahn DR. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth. 2007;99(3):316-328.
12. Levine GN, Bates ER, Blankenship JC, et al. 2011 accf/ aha/scai guideline for percutaneous coronary intervention: A report of the american college of cardiology foundation/ american heart association task force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation. 2011;124(23):e574-e651.
13. Himmelfarb J, Holbrook D, McMonagle E, Ault K. Increased reticulated platelets in dialysis patients. Kidney Int. 1997; 51(3):834-839.
14. Kaw D, Malhotra D. Platelet dysfunction and end-stage renal disease. Semin Dial. 2006;19(4):317-322.
15. Atwell TD, Smith RL, Hesley GK, et al. Incidence of bleeding after 15,181 percutaneous biopsies and the role of aspirin. AJR Am J Roentgenol. 2010;194(3):784-789.
16. Fox KA, Mehta SR, Peters R, et al. Clopidogrel in Unstable angina to prevent Recurrent ischemic Events Trial. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation. 2004;110(10):1202-1208.
17. Randolph AG, Cook DJ, Gonzales CA, Pribble CG. Ultrasound guidance for placement of central venous catheters: a meta-analysis of the literature. Crit Care Med. 1996;24(12):2053-2058.
18. Kerr A, Pathalapati R, Qiuhu S, Baumstein D. Purse-string suture to prevent bleeding after tunneled dialysis catheter insertion. J Vasc Interv Radiol. 2008;19(8):1176-1179.
19. Segal JB, Dzik WH; Transfusion Medicine/Hemostasis Clinical Trials Network. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion. 2005;45(9):1413-1425.
20. Haas B, Chittams JL, Trerotola SO. Large-bore tunneled central venous catheter insertion in patients with coagulopathy. J Vasc Interv Radiol. 2010;21(2):212-217.
21. Stecker MS, Johnson MS, Ying J, et al. Time to hemostasis after traction removal of tunneled cuffed central venous catheters. J Vasc Interv Radiol. 2007;18(10):1232-1239, quiz 1240.